About SPERO
Our Mission & Vision
Board of Directors
Management Team
Partners
Pipeline
SPR720
SPR206
Tebipenem HBr
Publications and Posters
PATIENTS
Nontuberculous Mycobacteria (NTM) Infections
Treating Antibiotic Resistance
Expanded Access
Careers
Current Job Listings
Life At Spero
Articles & Blogs
Benefits
Connect
Investor Relations
Press Releases
Events & Presentations
Stock Information
SEC Filings
Contact Us
ABOUT SPERO
Our Mission & Vision
Board of Directors
Management Team
Partners
PIPELINE
Our Pipeline
SPR720
SPR206
Tebipenem Hbr
Posters and Publications
PATIENTS
Nontuberculous Mycobacteria (NTM) Infections
Treating Antibiotic Resistance
Expanded Access
CAREERS
Current Job Listings
Life At Spero
Articles & Blogs
Benefits
CONNECT
Investor Relations
Press Releases
Events & Presentations
Stock Information
SEC Filings
Contact Us
Home
/
Article
/
Spero Article Post
The Anti-Infective Innovator Blog
Spero Therapeutics fetches $30 mln Series A
Spero Therapeutics fetches $30 mln Series A
The Anti-Infective Innovator Blog
Posted on
October 30, 2017
Written by Spero Therapeutics,
PE Hub
Sign up to receive news and announcements.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Recently Published
PASTEUR Act Reintroduced
Patients
Physicians Video Q & A
Pipeline
Explore Spero's Pipeline
